Opinion
Video
Author(s):
Key opinion leaders examine safety concerns and adverse event trends in psoriasis treatments, discussing how these factors influence decisions to discontinue therapy and transition patients to alternative interventions.
Integrating Nonsteroidal Topical Therapies in Plaque Psoriasis Care
The Cutaneous Connection: An Inside Look of the Inclusive Atlas
AI-Powered Innovation: Zasocitinib’s Journey to Precision Inhibition
The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics
Quality of Life Severely Affected for Patients with GPP
Deucravacitinib Shows Significant Efficacy and Safety in Phase 3b/4 Trial for Moderate to Severe Scalp Psoriasis